Regulatory Press Releases

Stille AB (publ) today presents the report for the fourth quarter and full year 2024. Revenue amounted to MSEK 159.8 (77.3) driven by strong organic growth in surgical instruments, the successful acquisition of Fehling and solid growth in the US. Total growth amounted to 106.4 percent, of which 22.0 percent was organic growth.“Earnings growth remains solid with an adjusted EBITDA margin of 28.4...

Stille AB (publ) announces the Nomination Committee's proposal for a new board composition for the 2025 Annual General Meeting. Chairman of the Board Lars Kvarnhem has declined re-election, and Jón Sigurdsson is proposed as the new Chairman of the Board. The Nomination Committee proposes the re-election of Per Carlsson, Yonna Olsson, Victor Steien, and Jens Viebke, and that Jón Sigurdsson...

Torbjörn Sköld has informed the board of his intentions to leave his role as CEO in June 2025 to focus on new professional opportunities. Torbjörn Sköld has a notice period of six months and will continue in his current role during that time. The board has now begun the process of recruiting his successor. "Torbjörn has played a central role in further developing and strengthening...

Stille AB (publ) proudly unveils the imagiQ3™, the next generation of C-arm tables, designed to set new standards in visualization, operating room efficiency and patient safety. Stille is proud to announce the launch of imagiQ3™, the next generation of advanced C-arm tables. With a commitment to product leadership and innovation, the new table is designed for ultimate visualization and...

Stille AB (publ) today presents the report for the third quarter 2024. Revenue amounted to MSEK 127.9 (70.1) driven by strong organic growth in surgical instruments and the successful acquisition of Fehling. Total growth amounted to 82.4 percent, of which 7.4 percent was organic growth.“Organic growth remained robust, despite high comparable figures and slightly lower demand in the surgical table...